Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

BACKGROUND: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. METHODS AND RESULTS: This multicenter retrospe...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hocqueloux, Laurent, Choisy, Philippe, Le Moal, Gwenaël, Borsa-Lebas, Françoise, Plainchamp, David, Legac, Eric, Prazuck, Thierry, de la Tribonnière, Xavier, Yazdanpanah, Yazdan, Parienti, Jean-Jacques
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494679/
https://ncbi.nlm.nih.gov/pubmed/23152890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0049289
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы